| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Docosahexaenoic Acid | Alzheimer's Disease | 18 | PM | 38373507 | 📋 | N-3 polyunsaturated fatty acids attenuate amyloid-beta-induced toxicity in AD transgenic Caenorhabditis elegans via promotion of proteasomal activity and activation of PPAR-gamma |
| Docosahexaenoic Acid | Alzheimer's Disease | 17 | PM | 37836528 | 📋 | Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice |
| Docosahexaenoic Acid | Alzheimer's Disease | 16 | PM | 36678710 | 📋 | Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer's Disease Mouse Model: Cellular and Molecular Correlates |
| Docosahexaenoic Acid | Alzheimer's Disease | 15 | PM | 35782939 | 📋 | DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 14 | PM | 35334816 | 📋 | Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer's Disease: Two-Year Follow-Up |
| Docosahexaenoic Acid | Alzheimer's Disease | 13 | PM | 35250535 | 📋 | A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 12 | PM | 34769257 | 📋 | Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue |
| Docosahexaenoic Acid | Alzheimer's Disease | 11 | PM | 34205196 | 📋 | DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration |
| Docosahexaenoic Acid | Alzheimer's Disease | 10 | PM | 34182090 | 📋 | Combination of docosahexaenoic acid and Ginko biloba extract improves cognitive function and hippocampal tissue damages in a mouse model of Alzheimer's disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 9 | PM | 33733657 | 📋 | DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 4 | PM | 33163896 | 📋 | Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats |
| Docosahexaenoic Acid | Alzheimer's Disease | 3 | PM | 32806612 | 📋 | Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? |
| Docosahexaenoic Acid | Alzheimer's Disease | 2 | PM | 32486013 | 📋 | Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects Against Aβ-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model |
| Docosahexaenoic Acid | Alzheimer's Disease | 1 | PM | 29695154 | 📋 | Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice |
| Docosahexaenoic Acid | Alzheimer's Disease | 8 | PM | 27825512 | 📋 | The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 6 | PM | 27532692 | 📋 | Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis |
| Docosahexaenoic Acid | Alzheimer's Disease | 5 | PM | 26606074 | 📋 | Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 7 | PM | 19686246 | 📋 | Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells |
| Docosahexaenoic Acid | Dementia | 2 | PM | 34759112 | 📋 | Intake of Docosahexaenoic Acid-Enriched Milk Beverage Prevents Age-Related Cognitive Decline and Decreases Serum Bone Resorption Marker Levels |
| Docosahexaenoic Acid | Dementia | 1 | PM | 32316172 | 📋 | Green Nut Oil or DHA Supplementation Restored Decreased Distribution Levels of DHA Containing Phosphatidylcholines in the Brain of a Mouse Model of Dementia |
| Docosahexaenoic Acid | Parkinson's Disease | 4 | PM | 38819068 | 📋 | Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease |
| Docosahexaenoic Acid | Parkinson's Disease | 3 | PM | 33279658 | 📋 | Contribution of DHA diols (19,20-DHDP) produced by cytochrome P450s and soluble epoxide hydrolase to the beneficial effects of DHA supplementation in the brains of rotenone-induced rat models of Parkinson's disease |
| Docosahexaenoic Acid | Parkinson's Disease | 1 | PM | 32001239 | 📋 | Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum |
| Docosahexaenoic Acid | Parkinson's Disease | 2 | PM | 28276272 | 📋 | Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet |
